Biotech
Seattle Genetics
Seattle Genetics raises $35B Public at $38B valuation
$35B
Total Raised
Public
Latest Round
1998
Founded
2000+
Employees
21823 30th Drive SE, Bothell, WA 98021
1 min read
Quick Facts
Valuation
$38B
Latest Round Size
$35B
Latest Round Date
January 2024
Seattle Genetics: Public Funding Round
Seattle Genetics has successfully raised $35B in Public funding, reaching a valuation of $38B.
Company Overview
Biotechnology company
Funding Details
The Public round was led by Public.
Company Information
- Headquarters: 21823 30th Drive SE, Bothell, WA 98021
- Founded: 1998
- Employees: 2000+
- Category: Biotech
Investment
Seattle Genetics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Public: Verified investor in Public
Key Investors
Public
Lead Investor
Verified investor in Public
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M